AbbVie Inc. Treasury Stock 2013-2026 | ABBV
Beta
What is treasury stock?
Treasury stock represents shares that were previously issued and later repurchased by the company, reducing total stockholders' equity.
What is AbbVie Inc.'s current treasury stock?
AbbVie Inc. (ABBV) annual treasury stock for 2025 was $9.15B, a 11.52% increase from 2024. AbbVie Inc. treasury stock for the quarter ending March 31, 2026 was $10.61B.
What was AbbVie Inc.'s treasury stock in 2024?
AbbVie Inc. annual treasury stock for 2024 was $8.20B, a 25.53% increase from 2023.
What was AbbVie Inc.'s treasury stock in 2023?
AbbVie Inc. annual treasury stock for 2023 was $6.53B, a 42.21% increase from 2022.
What is AbbVie Inc.'s 5-year treasury stock CAGR?
AbbVie Inc. treasury stock grew at a compound annual growth rate (CAGR) of 32.21% from FY2020 to FY2025, going from $2.26B to $9.15B over 5 years.
Treasury Stock History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+32.2%
FY2020
$2.26B
→
FY2025
$9.15B
13141516171819202122232425
5 years selected
Treasury Stock History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $9.15B | +11.5% | 10-K |
| FY2024 | $8.20B | +25.5% | 10-K |
| FY2023 | $6.53B | +42.2% | 10-K |
| FY2022 | $4.59B | +46.2% | 10-K |
| FY2021 | $3.14B | +38.8% | 10-K |
| FY2020 | $2.26B | -90.8% | 10-K |
| FY2019 | $24.50B | +1.6% | 10-K |
| FY2018 | $24.11B | +102.2% | 10-K |
| FY2017 | $11.92B | +9.9% | 10-K |
| FY2016 | $10.85B | +22.8% | 10-K |
| FY2015 | $8.84B | +809.4% | 10-K |
| FY2014 | $972.0M | +203.8% | 10-K |
| FY2013 | $320.0M | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →